Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Silexion Therapeutics ( (SLXN) ) is now available.
On March 25, 2026, Silexion Therapeutics Corp. announced that its Board of Directors unanimously removed Ilan Levin from his position as a board member, effective immediately. The action was taken in writing by all other directors under the company’s Amended and Restated Articles of Association, marking a notable change in the firm’s governance structure that may influence future board dynamics and strategic oversight.
The decision underscores the Board’s willingness to exercise its authority to reconfigure its membership when deemed necessary. While the company did not provide additional operational or strategic details in connection with Levin’s removal, the move signals an internal shift that stakeholders may view as significant for Silexion’s leadership and decision-making processes going forward.
The most recent analyst rating on (SLXN) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Silexion Therapeutics stock, see the SLXN Stock Forecast page.
Spark’s Take on SLXN Stock
According to Spark, TipRanks’ AI Analyst, SLXN is a Neutral.
The score is held down primarily by weak financial durability (no revenue and ongoing cash burn) and a bearish technical setup (below key moving averages with negative MACD). Corporate events provide some offset via the clinical trial approval, while valuation offers limited support given a non-meaningful negative P/E and no dividend.
To see Spark’s full report on SLXN stock, click here.
More about Silexion Therapeutics
Silexion Therapeutics Corp. operates in the therapeutics and broader life sciences sector, focusing on developing medical treatments and technologies. The company is governed by a Board of Directors under Amended and Restated Articles of Association, which define its corporate governance framework and procedures for board composition and changes.
Average Trading Volume: 42,988
Technical Sentiment Signal: Strong Sell
Current Market Cap: $4.46M
Find detailed analytics on SLXN stock on TipRanks’ Stock Analysis page.